{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:47:10Z","timestamp":1790192830574,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T00:00:00Z","timestamp":1582675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.kint.2020.01.045","type":"journal-article","created":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T17:44:51Z","timestamp":1582911891000},"page":"1260-1274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Long-term outcomes and response to treatment in diacylglycerol kinase epsilon nephropathy"],"prefix":"10.1016","volume":"97","author":[{"given":"Vicky","family":"Brocklebank","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurinder","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Howie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanthi","family":"Chandar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David V.","family":"Milford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Craze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Finlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Freundlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Inward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Mraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronte M.","family":"Corner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Smith-Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick R.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Marchbank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire L.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin K.S.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Malina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil S.","family":"Sheerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2020.01.045_bib1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2020.01.045_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1681\/ASN.2012090903","article-title":"DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GN","volume":"24","author":"Ozaltin","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.01.045_bib3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2215\/CJN.00620117","article-title":"Thrombotic microangiopathy and the kidney","volume":"13","author":"Brocklebank","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.01.045_bib4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2020.01.045_bib5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ki.2011.399","article-title":"Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion","volume":"81","author":"Sethi","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2020.01.045_bib6","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/nrneph.2012.213","article-title":"Pathogenesis of the C3 glomerulopathies and reclassification of MPGN","volume":"8","author":"Bomback","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2020.01.045_bib7","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1681\/ASN.2013070732","article-title":"Characterization of a factor H mutation that perturbs the alternative pathway of complement in a family with membranoproliferative GN","volume":"25","author":"Wong","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.01.045_bib8","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.1021\/cr1004106","article-title":"Regulation and functions of diacylglycerol kinases","volume":"111","author":"Shulga","year":"2011","journal-title":"Chem Rev"},{"key":"10.1016\/j.kint.2020.01.045_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ymgme.2009.02.011","article-title":"Phosphoinositide cycle gene polymorphisms affect the plasma lipid profile in the Quebec Family Study","volume":"97","author":"Dolley","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.kint.2020.01.045_bib10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3390\/ph6030407","article-title":"Protein kinase C inhibitors as modulators of vascular function and their application in vascular disease","volume":"6","author":"Khalil","year":"2013","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.kint.2020.01.045_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.bi.58.070189.000335","article-title":"The protein kinase C family: heterogeneity and its implications","volume":"58","author":"Kikkawa","year":"1989","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.kint.2020.01.045_bib12","doi-asserted-by":"crossref","first-page":"20903","DOI":"10.1074\/jbc.M200946200","article-title":"Protein kinase C induces actin reorganization via a Src- and Rho-dependent pathway","volume":"277","author":"Brandt","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2020.01.045_bib13","doi-asserted-by":"crossref","first-page":"F895","DOI":"10.1152\/ajprenal.00431.2015","article-title":"Loss of diacylglycerol kinase epsilon in mice causes endothelial distress and impairs glomerular Cox-2 and PGE2 production","volume":"310","author":"Zhu","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2020.01.045_bib14","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2215\/CJN.08520814","article-title":"Characterization of a new DGKE\u00a0intronic mutation in genetically unsolved cases of familial atypical\u00a0hemolytic uremic syndrome","volume":"10","author":"Mele","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.01.045_bib15","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2215\/CJN.01640214","article-title":"Complement mutations in diacylglycerol kinase-epsilon-associated atypical hemolytic uremic syndrome","volume":"9","author":"Sanchez Chinchilla","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.01.045_bib16","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1681\/ASN.2013080886","article-title":"Phenotypic expansion of DGKE-associated diseases","volume":"25","author":"Westland","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.01.045_bib17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/ped.12549","article-title":"Atypical hemolytic uremic syndrome: Korean pediatric series","volume":"57","author":"Lee","year":"2015","journal-title":"Pediatr Int"},{"key":"10.1016\/j.kint.2020.01.045_bib18","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1160\/TH15-01-0007","article-title":"Atypical haemolytic uraemic syndrome in a Japanese patient with DGKE genetic mutations","volume":"114","author":"Miyata","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.kint.2020.01.045_bib19","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1681\/ASN.2017010031","article-title":"The phenotypic spectrum of nephropathies associated with mutations in diacylglycerol kinase epsilon","volume":"28","author":"Azukaitis","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.01.045_bib20","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1182\/blood-2014-06-579953","article-title":"Loss of DGK\u03b5 induces endothelial cell activation and death independently of complement activation","volume":"125","author":"Bruneau","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.kint.2020.01.045_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/qjmed\/hcv082","article-title":"A\u00a0national specialized service in England for atypical haemolytic uraemic syndrome\u2014the first year\u2019s experience","volume":"109","author":"Sheerin","year":"2016","journal-title":"QJM"},{"key":"10.1016\/j.kint.2020.01.045_bib22","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.semnephrol.2013.08.003","article-title":"Atypical hemolytic uremic syndrome","volume":"33","author":"Kavanagh","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2020.01.045_bib23","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1073\/pnas.081536298","article-title":"Diacylglycerol kinase epsilon regulates seizure susceptibility and long-term potentiation through arachidonoyl-inositol lipid signaling","volume":"98","author":"Rodriguez de Turco","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2020.01.045_bib24","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1681\/ASN.2015101189","article-title":"Thrombotic microangiopathy in inverted formin 2-mediated renal disease","volume":"28","author":"Challis","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.01.045_bib25","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00467-016-3399-0","article-title":"Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity","volume":"32","author":"Beck","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2020.01.045_bib26","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/ckj\/sfx081","article-title":"Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea","volume":"10","author":"Brocklebank","year":"2017","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2020.01.045_bib27","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.kint.2017.04.028","article-title":"Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland","volume":"92","author":"Brocklebank","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2020.01.045_bib28","series-title":"Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura","first-page":"166","article-title":"Atypical hemolytic uremic syndrome","author":"Fitzpatrick","year":"1992"},{"key":"10.1016\/j.kint.2020.01.045_bib29","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/jpc.14390","article-title":"Eculizumab in paediatric atypical haemolytic uraemic syndrome: lessons learned from a single-centre experience in the United Arab Emirates","volume":"55","author":"Kumar","year":"2019","journal-title":"J\u00a0Paediatr Child Health"},{"key":"10.1016\/j.kint.2020.01.045_bib31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/kisup.2012.77","article-title":"Summary of recommendation statements","volume":"3","year":"2013","journal-title":"Kidney Int Suppl (2011)"},{"key":"10.1016\/j.kint.2020.01.045_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.imbio.2013.06.004","article-title":"Standardisation of the factor H autoantibody assay","volume":"219","author":"Watson","year":"2014","journal-title":"Immunobiology"},{"key":"10.1016\/j.kint.2020.01.045_bib33","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1086\/318203","article-title":"Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition","volume":"68","author":"Richards","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.kint.2020.01.045_bib34","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1681\/ASN.2005010103","article-title":"Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome","volume":"16","author":"Kavanagh","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.01.045_bib35","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.molimm.2005.06.041","article-title":"Does complement factor B have a role in the pathogenesis of atypical HUS?","volume":"43","author":"Kavanagh","year":"2006","journal-title":"Mol Immunol"},{"key":"10.1016\/j.kint.2020.01.045_bib36","doi-asserted-by":"crossref","first-page":"12966","DOI":"10.1073\/pnas.2135497100","article-title":"Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome","volume":"100","author":"Richards","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2020.01.045_bib37","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","article-title":"Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome","volume":"112","author":"Fremeaux-Bacchi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.kint.2020.01.045_bib38","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1681\/ASN.2015010100","article-title":"A\u00a0de novo deletion in the regulators of complement activation cluster producing a hybrid complement factor H\/complement factor H-related 3 gene in atypical hemolytic uremic syndrome","volume":"27","author":"Challis","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2020.01.045_bib39","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.imbio.2016.05.002","article-title":"Chromosomal rearrangement\u2014a rare cause of complement factor I associated atypical haemolytic uraemic syndrome","volume":"221","author":"Gleeson","year":"2016","journal-title":"Immunobiology"},{"key":"10.1016\/j.kint.2020.01.045_bib40","doi-asserted-by":"crossref","first-page":"D689","DOI":"10.1093\/nar\/gkz890","article-title":"Ensembl Genomes 2020\u2014enabling non-vertebrate genomic research","volume":"48","author":"Howe","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.kint.2020.01.045_bib41","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nprot.2015.053","article-title":"The Phyre2 web portal for protein modeling, prediction, and analysis","volume":"10","author":"Kelley","year":"2015","journal-title":"Nat Protoc"},{"key":"10.1016\/j.kint.2020.01.045_bib42","doi-asserted-by":"crossref","first-page":"D222","DOI":"10.1093\/nar\/gkt1223","article-title":"Pfam: the protein families database","volume":"42","author":"Finn","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.kint.2020.01.045_bib43","series-title":"The PyMOL Molecular Graphics System. v1.5.0.4","author":"DeLano","year":"2010"},{"key":"10.1016\/j.kint.2020.01.045_bib44","doi-asserted-by":"crossref","first-page":"D493","DOI":"10.1093\/nar\/gkx922","article-title":"20 years of the SMART protein domain annotation resource","volume":"46","author":"Letunic","year":"2018","journal-title":"Nucleic Acids Res"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525382030226X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525382030226X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:55:36Z","timestamp":1758761736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S008525382030226X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S008525382030226X"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2020.01.045","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcomes and response to treatment in diacylglycerol kinase epsilon nephropathy","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2020.01.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}